Old Web
English
Sign In
Acemap
>
authorDetail
>
Kae Matsuda-Nagasumi
Kae Matsuda-Nagasumi
Takeda Pharmaceutical Company
Insulin
Secretion
Endocrinology
Internal medicine
Free fatty acid receptor 1
2
Papers
70
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Fasiglifam exhibits positive cooperativity with γ-LA in intracellular Ca 2+ influx and insulin secretion.
2013
PLOS ONE
Chiori Yabuki
Hidetoshi Komatsu
Yoshiyuki Tsujihata
Risa Maeda
Ryo Ito
Kae Matsuda-Nagasumi
Kensuke Sakuma
Kazumasa Miyawaki
Naoya Kikuchi
Koji Takeuchi
Yugo Habata
Masaaki Mori
Show All
Source
Cite
Save
Citations (0)
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
2013
PLOS ONE
Chiori Yabuki
Hidetoshi Komatsu
Yoshiyuki Tsujihata
Risa Maeda
Ryo Ito
Kae Matsuda-Nagasumi
Kensuke Sakuma
Kazumasa Miyawaki
Naoya Kikuchi
Koji Takeuchi
Yugo Habata
Masaaki Mori
Show All
Source
Cite
Save
Citations (70)
1